A digital illustration of a construction site with multiple cranes in the background. The cranes are white and appear to be in the process of being built. In the center of the image there is a large American flag flying on top of one of the cranes. The sky is blue and there are a few workers visible in the foreground. The image also has the words "Building our future" written in white text on the bottom right corner. The logo of Mallinckrodt Pharmaceuticals is also visible on the top left corner.
Description 
Type
Category
Source 1 of 29
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
-
Date
2007
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![A screenshot of a Formulary update page on the Xartemis™ XR (oxycodone HCI and acetaminophen Extended-Release Tablets (CII)) website. It explains that "Xartemis™ Xu is available unrestricted on Tier 3 for State of Connecticut EMP (CT) Commercial Patients. No PA/step therapy requirement. Patients will have an average co-pay of [placeholder]." The page has a white green and grey background with purple menu bar at the bottom.](https://oida-resources-images.azureedge.net/public/full/2d0e21be-f2dc-4e52-a1df-81df18c3880c.jpeg)
![A bar graph that shows the results of a study about EXALGO. The graph is divided into three sections.<br /><br />The first section is titled "Studies show switching to EXALGO could provide long lasting analgesia" and shows that in its 12-week pivotal trial EXALGO reduced pain intensity at study endpoint and throughout the trial. The second section is labeled "Conversion/Treatment Phase" and has a blue arrow pointing to the left side of the graph. The third section is labeled "6.4 Week 1 [etc.]"](https://oida-resources-images.azureedge.net/public/full/20a0a652-bcb7-4362-871c-1be2d99a256b.jpeg)
